Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
HRTS
44
HOLDINGS
23%
ALSO IN THNR
THNR
19
HOLDINGS
53%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.8% | 13.2% | 10.8% |
|
MERCK & CO. INC. | 3.9% | 4.7% | 3.9% |
|
ABBVIE INC | 3.0% | 4.7% | 3.0% |
|
AMGEN INC | 2.0% | 6.8% | 2.0% |
|
REGENERON PHARMACEUTICALS | 2.0% | 6.8% | 2.0% |
HRTS Overweight Relative to THNR
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.8% |
|
UNITEDHEALTH GROUP INC | 4.4% |
 |
ASTRAZENECA PLC | 4.4% |
|
JOHNSON & JOHNSON | 4.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
ABBOTT LABORATORIES | 3.7% |
|
BOSTON SCIENTIFIC CORP | 3.1% |
|
GILEAD SCIENCES INC | 3.1% |
|
NOVARTIS AG | 3.0% |
 |
MEDTRONIC PLC | 2.9% |
HRTS Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -12.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.8% |
|
SHIONOGI & CO LTD | -4.8% |
|
PFIZER INC | -4.8% |
|
REGENERON PHARMACEUTICALS | -4.8% |
|
ROCHE HOLDING LTD | -4.8% |
|
AMGEN INC | -4.8% |
|
ASTRAZENECA PLC-SPONS ADR | -4.7% |
 |
INNOVENT BIOLOGICS, INC. | -4.6% |
 |
CHINA PHARMACEUTICAL GROUP | -4.1% |